{
  "nctId": "NCT02875392",
  "briefTitle": "Fucoidan Improves the Metabolic Profiles of Patients With Non-alcoholic Fatty Liver Disease (NAFLD)",
  "officialTitle": "Fucoidan Improves the Metabolic Profiles of Patients With Non-alcoholic Fatty Liver Disease (NAFLD)",
  "protocolDocument": {
    "nctId": "NCT02875392",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2016-07-04",
    "uploadDate": "2021-01-18T03:05",
    "size": 334844,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02875392/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "DOUBLE",
  "enrollmentInfo": {
    "enrollmentCount": 57,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2016-11",
    "completionDate": "2018-03",
    "primaryCompletionDate": "2017-10",
    "firstSubmitDate": "2016-08-05",
    "firstPostDate": "2016-08-23"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Patients who are aged between 20-75 with non alcoholic fatty liver disease (NAFLD).\n\nExclusion Criteria:\n\n1. Patients were allergic to seafood.\n2. Patients who take Vitamin E or Pioglitazone.",
    "healthyVolunteers": true,
    "sex": "ALL",
    "minimumAge": "20 Years",
    "maximumAge": "75 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Change in ALT Index",
        "description": "Measure the first month and the sixth-month change in the index which is ALT related to Liver inflammation.",
        "timeFrame": "6 months"
      },
      {
        "measure": "Change in AST Index",
        "description": "Measure the first month and the sixth-month change in the index which is AST relate to Liver inflammation",
        "timeFrame": "6 months"
      },
      {
        "measure": "Change in HbA1c",
        "description": "Measure the first month and the sixth-month change in the index which is HbA1c relate to Liver inflammation",
        "timeFrame": "6 months"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 3,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 3
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 59,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T02:30:11.742Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}